The largest database of trusted experimental protocols

8 protocols using fixable viability stain 575v

1

Multiparametric Flow Cytometry Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine different cell populations within human melanoma patient PBMC and mouse Pmel-1 splenocytes, cell surface flow cytometry was performed as previously described.27 (link) Human melanoma patient PBMC were stained with the following anti-human antibodies from BD: Fixable Viability Stain 575V, CD3 APC-R700, CD19 APC-H7, CD47 APC, PD-1 BV 421, and CD8 BUV496. Pmel-1 splenocytes were stained with dilutions of the following anti-mouse antibodies from BD: CD19 BV421, Fixable Viability Stain 575V, CD64 BV786, CD8a APC-H7, and CD3 BUV496. Flow cytometry was performed on the BD LSRFortessa X-20 Analyzer, and analysis was performed on FCS Express software (online supplemental figures 3C and 3D).
+ Open protocol
+ Expand
2

High-parameter flow cytometry analysis of immune cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
High-parameter flow cytometry was performed on BAL cells and PBMCs at preinfection, at pretreatment, during treatment, at posttreatment, and at necropsy as previously described (17 (link), 34 (link), 66 (link), 74 (link), 77 (link)). The single cells prepared from lung, BAL, PBMCs, and other tissues were stained with surface and intracellular markers to study T cell phenotypes. Tissues obtained at necropsy were digested using Liberase and DNase (both Sigma-Aldrich), filtered, and subjected to RBC lysis (ACK Lysis Buffer, Gibco). The cells were then counted and used for staining for flow cytometry. The cells were first stained with extracellular/surface antibodies: CD3, CD4, CD8, CD45, CD28, and CD95 for 25 minutes at room temperature, followed by the Fixable Viability Stain 575V (BD Biosciences). The cells were then fixed and permeabilized using Fixation/Permeabilization Kit (BD Biosciences) for 30 minutes at 4°C. Subsequently, the cells were stained with intracellular antibody (Ki67) to study the T cell proliferation. Cells were then washed and acquired on a BD FACSSymphony flow cytometer. Analysis was performed using FlowJo (v10.5.3) using previously published gating strategies (Supplemental Figure 4) (30 (link), 32 (link)–34 (link)). The details of antibodies used in flow cytometry experiments are provided (Supplemental Table 3).
+ Open protocol
+ Expand
3

Flow Cytometry Analysis of Single-Cell Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
SCS were processed both with and without red blood cell lysis by BD Pharm Lyse buffer following manufacturer’s instructions prior to staining. Briefly, SCS and enriched cell populations were washed with PBS before staining with Fixable Viability Stain 575V (BD Biosciences) at 1:1,000 dilution for 15 min at RT. Then, cells were washed with PBS -1% FBS (Gibco) and incubated for 15 min at RT with antibodies against surface markers (Supplementary Data Sheet 2) in Cell separation buffer [(1X MACS separation buffer (Miltenyi Biotec) supplemented with 0.5% BSA (Sigma)]. Cells were further washed with Cell separation buffer prior acquisition in LSR Fortessa flow cytometer (BD). Instrument settings are shown in Supplementary Data Sheet 3. For each sample, a minimum of 105 cells was acquired. Controls included unstained samples and single fluorochrome compensation beads. Results were analyzed using FlowJo software 10.6.2.
+ Open protocol
+ Expand
4

Cytokine Responses in Cutaneous Leishmaniasis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma IFN-γ was measured using BioPlex-220 (Bio-Rad Laboratories) with Cytokine Grp-I-panel 27-plex. Peripheral blood mononuclear cells from a subset (n = 40) of untreated phase 2 CL patients were separated from heparinized blood over Ficoll and used to examine T-cell responses by IFNG-AS1 genotype. Cells (1 × 106 cells/mL) were stimulated: 37°C/5% CO2, 10 μg/mL L. braziliensis (strain MHOM/BR/2001) log-phase promastigote soluble Leishmania antigen, 1 μg/mL purified NA/LE anti-human CD28 (clone CD28.2, BD Biosciences, San Jose, California) for 15 hours, then brefeldin A (BD Biosciences) for 4 hours. Washed cells (phosphate-buffered saline/0.2% bovine serum albumin) were incubated (4°C; 30 minutes) with BUV661 anti-human CD3 monoclonal antibody (UCHT1 clone, BD Biosciences). Cells were fixed, washed, permeabilized using BD Cytofix/Cytoperm, and incubated (4°C; 30 minutes) with BV605 anti-human IFN-γ (B27 clone) and BUV395 anti-human TNF-α (MAB11 clone, BD Biosciences) in permeabilization buffer. Live/dead cells were distinguished using Fixable Viability Stain 575V (BD Biosciences). Data were acquired by BD FACSymphony A5 flow cytometry and analyzed using FlowJo 10.6.1 software (BD Biosciences), and differences between genotypes determined using nonparametric Kruskal-Wallis analysis of variance (ANOVA) with multiple comparisons.
+ Open protocol
+ Expand
5

Multiparametric Blood Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected from the inguinal veins at the indicated time points (Fig. 1A) and hematological examination was conducted using an autohematology analyzer (Mindray BC-5000; Mindray, Shenzhen, China). Flow cytometric analysis was performed using a BD LSR Fortessa flow cytometer (BD Biosciences, San Jose, CA, USA) and analyzed using FlowJo v10.7.1 (BD Biosciences), as previously described (8 (link)). To exclude dead cells, blood was first stained with Fixable Viability Stain 575V (BD Biosciences) for 20 min at room temperature. For surface staining, cells were stained with the following antibodies for 30 min at 4°C: CD3 (Alexa Fluor 700; Invitrogen, Waltham, MA, USA), CD20 (APC/Cyanine7; Invitrogen), CD27 (PE/Cyanine7; Invitrogen), IgD (PE; BioLegend Inc., San Diego, CA, USA), IgM (FITC; SouthernBiotech, Birmingham, AL, USA), IgG (V450; BD Bioscience), CD4 (V500; Invitrogen), CD8 (V450; Invitrogen), CD95 (PE/Cyanine5; Invitrogen), and CD28 (ECD; Beckman Coulter, Brea, CA, USA). The cells were washed with permeabilization wash buffer and fixed with 1% paraformaldehyde. Data were acquired using an LSR Fortessa system (BD Biosciences) and analyzed using FlowJo v10.7.1 (BD Biosciences).
+ Open protocol
+ Expand
6

Multiparameter flow cytometry analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with 10% mouse serum (Sigma‐Aldrich), 10% rat serum (Sigma‐Aldrich) and 10% MACS buffer (Miltenyi Biotec, Bergisch Gladbach, Germany) at a 1:1:1 ratio for 10 min at 4°C to block the non‐specific binding, as described in a previous study.
38 (link) Cells were then washed with PBS and performed LiveDead staining with Fixable Viability Stain 575 V (BD Biosciences, San Jose, USA) or Zombie Aqua™ Fixable Viability Kit (Biolegend, San Deigo, USA) for 10 min at 4°C in the dark. Cells were subsequently washed with MACS buffer and stained with other cell surface antibodies for 15–20 min at 4°C. The expression of NK cell receptors and immune checkpoints on NK cells were analysed using a 21‐colour flow cytometry panel (Supplementary table 1) and the expression of the corresponding ligands on the tumor cells was analysed using a 20‐colour flow cytometry panel (Supplementary tables 2 and 3). The cells were then washed and resuspended in MACS buffer and acquired on a FACSymphony A5 instrument (BD Biosciences).
+ Open protocol
+ Expand
7

Flow cytometry of DENV-infected PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following infection with AF594-labelled DENVs, PBMCs of humans or non-human primate were stained first with Fixable Viability Stain 575V (BD Biosciences, USA) at 20 °C for live/dead cell gating, followed by surface staining with CD14, HLA-DR, CD16, CD20, and CD3. PBMCs were then analysed using a LSR Fortessa system (BD Bioscience) and FlowJo software v10.7.1.
+ Open protocol
+ Expand
8

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleen, lymph nodes and/or tumors were harvested and passed through a 70 µm metal mesh and red blood cell lysed. Resulting single cell suspensions were stained with monoclonal antibodies specific for mouse CD8α (53-6.7), CD45.1 (A20), Vα2 (B20.1), IFNγ (XMG1.2), PD-1 (29F-1412), MHCI (AF6-88.5), CD45 (30-F11), and/or NK1.1 (PK1136) (all from BD Biosciences). For ex vivo cytokine production assays, splenocytes were first restimulated with 1 µM gB498-505 peptide for 1 h at 37 °C prior to addition of 0.22 mg Brefeldin A (BD GolgiPlug™, BD Biosciences) for a further 4 h. Following surface stain, cells were fixed with 4% paraformaldehyde prior to permeabilization with Permeabilization Buffer (eBioscience) and staining with IFNγ. Cells were stained with Fixable Viability Stain 575V at 1:20,000 (BD Biosciences) prior to surface staining or propidium iodide (PI; Sigma) immediately prior to acquisition to exclude dead cells. Cells were analyzed using the BD LSRFortessa and FlowJo software (BD Biosciences/TreeStar).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!